Showing results (11-20 of 79) with videos related to
Sort By:
Pageof 8
Molecular Pharmaceutics|April 11, 2015
Inhibition of bcr-abl in human leukemic cells with a coiled-coil protein delivered by a leukemia-specific cell-penetrating PeptideBenjamin J Bruno, Carol S LimMolecular Pharmaceutics|December 6, 2012
Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferationDavid W Woessner, Carol S LimAAPS Pharmsci|November 9, 2002
Model system to study classical nuclear export signalsCharu Kanwal, Henan Li, Carol S LimTherapeutic Delivery|November 30, 2010
Controlling subcellular delivery to optimize therapeutic effectMohanad Mossalam, Andrew S Dixon, Carol S LimMolecular Pharmaceutics|February 13, 2013
Controlled access of p53 to the nucleus regulates its proteasomal degradation by MDM2James R Davis, Mohanad Mossalam, Carol S LimPharmaceutical Research|August 8, 2012
Utilizing the estrogen receptor ligand-binding domain for controlled protein translocation to the insoluble fractionJames R Davis, Mohanad Mossalam, Carol S LimPharmaceutical Research|September 14, 2006
Controlling protein compartmentalization to overcome diseaseJames R Davis, Mudit Kakar, Carol S LimMolecular Pharmaceutics|December 6, 2005
Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activityHenan Li, Matthew L Fidler, Carol S LimCancer Journal (Sudbury, Mass.)|December 14, 2011
Development of an effective therapy for chronic myelogenous leukemiaDavid W Woessner, Carol S Lim, Michael W DeiningerMolecular Pharmaceutics|March 17, 2010
Effect of anabolic-androgenic steroids and glucocorticoids on the kinetics of hAR and hGR nucleocytoplasmic translocationAmy B Cadwallader, Douglas E Rollins, Carol S LimPageof 8